Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
Holding BEAM?
Track your performance easily

Beam Therapeutics (BEAM) Technical Analysis

1,279 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
6Neutral
14Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Beam Therapeutics’s (BEAM) Moving Averages Convergence Divergence (MACD) indicator is 0.73, suggesting Beam Therapeutics is a Sell.
Beam Therapeutics’s (BEAM) 20-Day exponential moving average is 25.27, while Beam Therapeutics’s (BEAM) share price is $24.05, making it a Sell.
Beam Therapeutics’s (BEAM) 50-Day exponential moving average is 24.85, while Beam Therapeutics’s (BEAM) share price is $24.05, making it a Sell.

Beam Therapeutics (BEAM) Pivot Points

Nov 17, 2024, 04:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
24.12
25.16
25.74
26.78
27.35
28.39
28.97
Fibonacci
25.16
25.78
26.16
26.78
27.40
27.78
28.39
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Beam Therapeutics (BEAM) Moving Averages

Nov 17, 2024, 04:16 PM
Period
Simple
Exponential
MA5
27.23Sell
26.08Sell
MA10
26.42Sell
25.95Sell
MA20
24.37Sell
25.27Sell
MA50
24.50Sell
24.85Sell
MA100
25.27Sell
25.12Sell
MA200
26.81Sell
26.35Sell
Beam Therapeutics’s (BEAM) 10-Day exponential moving average is 25.95, while Beam Therapeutics’s (BEAM) share price is $24.05, making it a Sell.
Beam Therapeutics’s (BEAM) 100-Day exponential moving average is 25.12, while Beam Therapeutics’s (BEAM) share price is $24.05, making it a Sell.
Beam Therapeutics’s (BEAM) stock price is $24.05 and Beam Therapeutics’s (BEAM) 50-day simple moving average is 24.50, creating a Sell signal.
Beam Therapeutics’s (BEAM) stock price is $24.05 and Beam Therapeutics’s (BEAM) 100-day simple moving average is 25.27, creating a Sell signal.
Beam Therapeutics’s (BEAM) stock price is $24.05 and Beam Therapeutics’s (BEAM) 200-day simple moving average is 26.81, creating a Sell signal.

Beam Therapeutics (BEAM) Technical Indicators

Nov 17, 2024, 04:16 PM
Name
Value
Implied Action
RSI (14)
46.67
Neutral
STOCH (9,6)
41.49
Neutral
STOCHRSI (14)
41.49
Neutral
MACD (12,26)
0.73
Sell
ADX (14)
24.62
Neutral
Williams %R
-76.08
Buy
CCI (14)
9.33
Neutral
ATR (14)
1.94
-
Ultimate Oscillator
43.32
Neutral
ROC
7.61
Buy
Beam Therapeutics’s (BEAM) Relative Strength Index (RSI) is 46.67, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Trend Strength Indicator (ADX) is 24.62, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Commodity Channel Index (CCI) is 9.33, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Price Rate of Change (ROC) is 7.61, creating a Buy signal.

FAQ

Is BEAM a Buy, Hold, or Sell?
Based on BEAM’s technical indicators, BEAM is a Strong Sell.
    What is BEAM’s RSI (14)?
    BEAM’s RSI (14) is 46.67, which suggests BEAM is a Neutral.
      What is BEAM’s MACD?
      BEAM’s MACD is 0.73, which suggests BEAM is a Sell.
        What is BEAM’s 5-day moving average?
        BEAM’s 5-day moving average is 27.23, which suggests BEAM is a Sell.
          What is BEAM’s 20-day moving average?
          BEAM 20-day moving average is 24.37, which suggests BEAM is a Sell.
            What is BEAM’s 50-day moving average?
            BEAM’s 50-day moving average is 24.50, which suggests BEAM is a Sell.
              What is BEAM’s 200-day moving average?
              BEAM’s 200-day moving average is 26.81, which suggests BEAM is a Sell.
                What is BEAM’s Williams % R (14)?
                BEAM’s Williams % R (14) is -76.08, which suggests BEAM is a Buy.
                  What is BEAM’s CCI (14)?
                  BEAM’s CCI (14) is 9.33, which suggests BEAM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis